InsidersTradesSigma
Total declarations
Company
▲ Purchases (13 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by KATZ MICHAEL W, Dirigeant. Director active across 1 companies, notably Organogenesis Holdings Inc.. Aggregated, 13 disclosures have been logged. Total volume traded: €401k. The latest transaction was filed on 16 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations13 total
€22,9344,000 shares@ €5.73350.0035% mcap5.7% of flow
Class A Common Stock
SEC:0001062993-22-012917:0·
Ideal exit: 10 Feb 2023 (T+270)
€4,265500 shares@ €8.53090.0006% mcap2.3% of flow
Class A Common Stock
SEC:0001062993-21-012871·
Ideal exit: 9 Sept 2022 (T+270)
€4,265500 shares@ €8.53090.0006% mcap1.1% of flow
Class A Common Stock
SEC:0001062993-21-012871:0·
Ideal exit: 9 Sept 2022 (T+270)
€8,6131,000 shares@ €8.61340.0013% mcap4.6% of flow
Class A Common Stock
SEC:0001062993-21-012263·
Ideal exit: 29 Aug 2022 (T+270)
€8,6131,000 shares@ €8.61340.0013% mcap2.1% of flow
Class A Common Stock
SEC:0001062993-21-012263:0·
Ideal exit: 29 Aug 2022 (T+270)
€8,6341,000 shares@ €8.63350.0013% mcap4.6% of flow
Class A Common Stock
SEC:0001062993-21-011910·
Ideal exit: 26 Aug 2022 (T+270)
€8,6341,000 shares@ €8.63350.0013% mcap2.2% of flow
Class A Common Stock
SEC:0001062993-21-011910:0·
Ideal exit: 26 Aug 2022 (T+270)
€8,7601,000 shares@ €8.76030.0013% mcap4.6% of flow
Class A Common Stock
SEC:0001062993-21-011825·
Ideal exit: 23 Aug 2022 (T+270)
€8,7601,000 shares@ €8.76030.0013% mcap2.2% of flow
Class A Common Stock
SEC:0001062993-21-011825:0·
Ideal exit: 23 Aug 2022 (T+270)
€19,7372,000 shares@ €9.86830.0030% mcap10.4% of flow
Class A Common Stock
SEC:0001661181-21-000071·
Ideal exit: 9 Aug 2022 (T+270)
€19,7372,000 shares@ €9.86830.0030% mcap4.9% of flow
Class A Common Stock
SEC:0001661181-21-000071:0·
Ideal exit: 9 Aug 2022 (T+270)
€138,85912,000 shares@ €11.57160.021% mcap73.5% of flow
Class A Common Stock
SEC:0001661181-21-000066·
Ideal exit: 14 May 2022 (T+270)
€138,85912,000 shares@ €11.57160.021% mcap34.7% of flow
Class A Common Stock
SEC:0001661181-21-000066:0·
Ideal exit: 14 May 2022 (T+270)
13 of 13 declarations
About KATZ MICHAEL W
KATZ MICHAEL W is an executive at Organogenesis Holdings Inc. In this role, he contributes to managing the company's operations and implementing its strategy. His expertise is valuable for supporting Organogenesis Holdings Inc.'s initiatives.
